XML 54 R33.htm IDEA: XBRL DOCUMENT
v3.23.1

Loss per share | 12 Months Ended
--- | ---
Dec. 31, 2022
Loss per share |
Loss per share |
25. | Loss per share
Basic and diluted net loss per share for the years ended December 2020, 2021 and 2022 have been calculated as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended December 31,
​ |  | 2020 |  | 2021 |  | 2022
​ | ​ | RMB | ​ | RMB | ​ | RMB
Numerator: | ​ | ​ | ​ | ​ |  |
Net loss attributable to ECARX Holdings Inc. |  | (439,659) | ​ | (1,180,921) |  | (1,540,015)
Accretion of Redeemable Convertible Preferred Shares |  | (101,286) | ​ | (243,564) |  | (354,878)
Numerator for basic and diluted net loss per share calculation |  | (540,945) | ​ | (1,424,485) |  | (1,894,893)
​ | ​ | ​ | ​ | ​ | ​ | ​
Denominator: |  | ​ | ​ |  |  |
Weighted average number of ordinary shares – basic and diluted |  | 238,591,421 | ​ | 236,691,093 |  | 239,296,386
Net loss per share attributable to ordinary shareholders |  | ​ | ​ |  |  |
— Basic and diluted |  | (2.27) | ​ | (6.02) |  | (7.92)
​ For the purposes of calculating loss per share for the years ended December 31, 2020, 2021 and 2022, the weighted average number of ordinary shares outstanding used in the calculation has been retrospectively adjusted to reflect the issuance of Class A and Class B ordinary shares in connection with the Recapitalization (see Note 1(b)), as if the Reorganization had occurred at the beginning of the earliest period presented. ​ The potentially dilutive instruments that have not been included in the calculation of diluted loss per share as their inclusion would be anti-dilutive are as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended December 31,
​ |  | 2020 |  | 2021 |  | 2022
Redeemable convertible preferred shares |  | 26,841,535 | ​ | 90,724,289 |  | —
Warrants |  | 6,016,207 | ​ | — |  | 23,871,971
​ For the years ended December 31, 2020 and 2021 and the period between January 1, 2022 to the completion of the Company’s Merger with COVA, the outstanding share options are not included in the calculation of diluted loss per share, as the issuance of such awards was contingent upon a qualified IPO, which was not satisfied as of each period end. After the Merger, the vested and unvested share options and warrants are not included in the calculation of basic or diluted loss per share, given the exercise price exceeded average market price of the Company’s shares during the period, resulting in the effect of them being anti-dilutive. ​ Convertible notes are not included in the calculation of diluted loss per share, as the inclusion will be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration